Madrigal Pharmaceuticals, Inc.
MDGLNASDAQHealthcare● Active
$486.98
$-5.85(-1.19%)
Market Cap$11.2B
P/E Ratio—
52W High$615
52W Low$271.96
Madrigal Pharmaceuticals, Inc.（MDGL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDGL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.96B | $0.18B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.06B | $0.01B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.90B | $0.17B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 94.14% | 96.54% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.39B | $0.24B | $0.27B | $0.25B | $0.21B |
| G&A Expenses | $0.00B | $0.00B | $0.11B | $0.05B | $0.04B |
| Total Operating Expenses | $1.20B | $0.67B | $0.38B | $0.29B | $0.24B |
| Operating Income | ($0.30B) | ($0.50B) | ($0.38B) | ($0.29B) | ($0.24B) |
| Operating Margin %(computed) | -31.31% | -276.39% | — | — | — |
| Interest Income | $0.04B | $0.05B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.29B) | ($0.47B) | ($0.37B) | ($0.30B) | ($0.24B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.29B) | ($0.47B) | ($0.37B) | ($0.30B) | ($0.24B) |
| Net Margin %(computed) | -30.08% | -258.64% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-12.85 | $-21.90 | $-19.99 | $-17.23 | $-14.63 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | ($0.26B) | ($0.45B) | ($0.36B) | ($0.29B) | ($0.24B) |
| EBITDA Margin %(computed) | -27.59% | -249.88% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Madrigal Pharmaceuticals, Inc.
关于Madrigal Pharmaceuticals, Inc.（MDGL）损益表
Madrigal Pharmaceuticals, Inc.（MDGL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MDGL实现营收$0.96B，毛利润$0.90B（毛利率94.14%），净利润($0.29B)（净利率-30.08%）。
常见问题
MDGL · 4 问Madrigal Pharmaceuticals, Inc.（MDGL）2025财年营收为$0.96B，同比up432.1%。
MDGL revenueMDGL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08